Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXL1M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,260
Award facts
- Contract value 100% obligated
- $13,260.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,260.06 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Zepbound 5 mg/0.5 mL pen injections. This firm fixed-price, non-set-aside contract is expected to be completed by January 30, 2026, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The award of this task order reflects the contractor's demonstrated capability to meet federal procurement requirements through competitive solicitation and its established role within DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FXL1M?
SPE2DR26FXL1M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FXL1M worth?
The government has obligated $13,260 on SPE2DR26FXL1M.
Is contract SPE2DR26FXL1M an order under another contract?
Yes. SPE2DR26FXL1M is a delivery order under SPE2DR25D6037, an indefinite delivery contract.
Was contract SPE2DR26FXL1M competed?
The extent of competition for SPE2DR26FXL1M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award